Floatz logo

Azacitidine

Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11

The First Affiliated Hospital of Soochow UniversitySmall moleculePhase 2Active
BBB
73/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
95/ 100

Competitive context

7 Active assets in the Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 cohort.

Asset / SponsorPhaseRating
Daunorubicin
National Cancer Institute (NCI)
Phase 3BBB
Idarubicine
Bruno C. Medeiros
Phase 2BBB
Fludarabine
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phase 2BBB
Cytosin-Arabinosid
Alice Mims
Phase 3BBB
ETOPOSIDE
Alice Mims
Phase 3BBB

View all 50 →

Same molecule, other indications

Azacitidine is also rated in:

non-small cell lung carcinomaDormant
BB
Indicative ·
71 / 100
View asset →
acute erythroid leukemiaDormant
BB
Indicative ·
71 / 100
View asset →
acute myeloid leukemia with 11q23 abnormalitiesDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →